GlobeNewswire by notified

Tecan to present at upcoming Investor Conferences

9.1.2023 14:30:00 CET | GlobeNewswire by notified

Share

Männedorf, Switzerland, January9, 2023 – The Tecan Group (SIX Swiss Exchange: TECN) today announced that it will attend and present at the following investor conferences this week:

41st Annual J.P. Morgan Healthcare Conference, San Francisco
Date: 11 January 2023
Presentation: 5:15 pm PST (2:15 am CET)
Presenter: Dr. Achim von Leoprechting, CEO, Tecan
Webcast live under the "Investor Relations" tab of Tecan's website www.tecan.com
A replay of the webcast will be available after the presentation and will remain available for 30 days.

Baader Helvea Swiss Equities Conference, Bad Ragaz
Date: 12 January 2023
Presentation: 12:00 pm CET
Presenter: Tania Micki, CFO, Tecan
Not webcasted        

Octavian Seminar 2023, Flims
Date: 13 January 2023
Participants: Tania Micki, CFO, Tecan & Martin Brändle, SVP, Corp. Comm. & IR, Tecan
Not webcasted

About Tecan
Tecan (www.tecan.com) improves people’s lives and health by empowering customers to scale healthcare innovation globally from life science to the clinic. Tecan is a pioneer and global leader in laboratory automation. As an original equipment manufacturer (OEM), Tecan is also a leader in developing and manufacturing OEM instruments, components and medical devices that are then distributed by partner companies. Founded in Switzerland in 1980, the company has more than 3,000 employees, with manufacturing, research and development sites in Europe, North America and Asia, and maintains a sales and service network in over 70 countries. In 2021, Tecan generated sales of CHF 947 million (USD 1,041 million; EUR 877 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TECN; ISIN CH0012100191).

For further information:

Tecan Group
Martin Braendle
Senior Vice President, Corporate Communications & IR
Tel. +41 (0) 44 922 84 30
Fax +41 (0) 44 922 88 89
investor@tecan.com
www.tecan.com

Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Ecorobotix Develops New Crop Algorithms for its AI-Powered Software7.5.2024 11:00:00 CEST | Press release

YVERDON-LES-BAINS, Switzerland, May 07, 2024 (GLOBE NEWSWIRE) -- Ecorobotix, a sustainable Swiss Agtech firm, active in the field of AI-based weeding, proudly announces the ongoing development of its newest AI software algorithms, now available as “beta versions” for testing by Ecorobotix clients. These new algorithms mark a significant advancement in crop compatibility, offering new application possibilities for the ARA ultra-high precision sprayer. Which new crop algorithms are under development? Dicots in wheatCarrotsVolunteer potatoes in chicoryDock + ThistleCottonSoy Clients with an ARA sprayer can access these crop algorithms free of charge for a limited time. New clients in 2024 can also benefit from this opportunity. Clients interested in testing these algorithms are encouraged to reach out to the Ecorobotix sales team to update their ARA. Among the algorithms, the carrot algorithm stands out as particularly robust, already garnering praise from early adopters, with recent feed

DSV, 1106 - SHARE BUYBACK IN DSV A/S7.5.2024 09:53:54 CEST | Press release

Company Announcement No. 1106 On 24 April 2024, we initiated a share buyback programme, as described in Company Announcement No. 1104. According to the programme, the company will in the period from 24 April 2024 until 23 July 2024 purchase own shares up to a maximum value of DKK 1,000 million, and no more than 1,700,000 shares, corresponding to 0.79% of the share capital at commencement of the programme. The programme has been implemented in accordance with Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (“MAR”) (save for the rules on share buyback programmes set out in MAR article 5) and the Commission Delegated Regulation (EU) 2016/1052, also referred to as the Safe Harbour rules. Trading dayNumber of shares bought backAverage transaction priceAmount DKKAccumulated trading for days 1-3145,0001,013.69146,985,0504:29 April 202475,0001,014.7176,103,2505:30 April 20247,0001,002.427,016,9406:1 May 20249,680993.049,612,6277:2 May 20247,320990.197,248,1918:3

Coloplast Finance B.V. - Interim Financial Report, H1 2023/247.5.2024 09:51:03 CEST | Press release

H1 2023/24 Interim financial results, H1 2023/24 1 October 2023 - 31 March 2024 Coloplast delivered a solid Q2 with 8% organic growth and an EBIT margin1) of 27%. Reported revenue in DKK grew 9% with 4%-points contribution from Kerecis (underlying growth of around 35%), partly offset by currencies. Organic growth rates by business area: Ostomy Care 7%, Continence Care 8%, Voice and Respiratory Care 13%, Advanced Wound Care 8% (Advanced Wound Dressings 8%) and Interventional Urology 5%.Continued good momentum in Chronic Care. Ostomy Care growth was driven by broad-based contribution from Emerging markets and Europe, compensating for lower growth in the US which was held back by order phasing and now expected to be H2 weighted. Continence Care growth was driven by intermittent catheters, including good contribution from LujaTM. Voice and Respiratory Care had a strong Q2, driven by double-digit growth in both laryngectomy and tracheostomy.Growth in Advanced Wound Dressings was broad-based

HiddenA line styled icon from Orion Icon Library.Eye